Literature DB >> 8494052

Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.

T Kawamata1, I Tooyama, T Yamada, D G Walker, P L McGeer.   

Abstract

Lactotransferrin (LF) expression was investigated immunocytochemically in postmortem brain tissues of normal controls and patients with Alzheimer's disease (AD). The antibody to LF stained some neurons weakly in young adult brains, but it stained many neurons as well as the glia of all types in elderly brains. LF expression was greatly up-regulated in both neurons and glia in affected AD tissue. It was very strongly associated with such extracellular pathological entities as diffuse and consolidated amyloid deposits and extracellular neurofibrillary tangles. In addition, it was identified in a minority of intracellular neurofibrillary tangles, neuropil threads, and degenerative neurites. LF is an iron scavenger and a complement inhibitor. Up-regulation may be a defense mechanism in AD-affected brain tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494052      PMCID: PMC1886898     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  A bactericidal effect for human lactoferrin.

Authors:  R R Arnold; M F Cole; J R McGhee
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

2.  Lactoferrin-mediated modulation of mononuclear cell activities. I. Suppression of the murine in vitro primary antibody responses.

Authors:  R L Duncan; W P McArthur
Journal:  Cell Immunol       Date:  1981-09-15       Impact factor: 4.868

3.  Lactoferrin interacts with deoxyribonucleic acid: a preferential reactivity with double-stranded DNA and dissociation of DNA-anti-DNA complexes.

Authors:  R M Bennett; J Davis
Journal:  J Lab Clin Med       Date:  1982-01

4.  Inhibition of lipid peroxidation by the iron-binding protein lactoferrin.

Authors:  J M Gutteridge; S K Paterson; A W Segal; B Halliwell
Journal:  Biochem J       Date:  1981-10-01       Impact factor: 3.857

5.  Plasma myeloperoxidase and lactoferrin measured by radioimmunoassay: relations to neutrophil kinetics.

Authors:  N E Hansen; J Malmquist; J Thorell
Journal:  Acta Med Scand       Date:  1975-12

6.  Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain.

Authors:  P L McGeer; D G Walker; H Akiyama; T Kawamata; A L Guan; C J Parker; N Okada; E G McGeer
Journal:  Brain Res       Date:  1991-03-29       Impact factor: 3.252

7.  Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system.

Authors:  D R Ambruso; R B Johnston
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

8.  Elevated circulating tumor necrosis factor levels in Alzheimer's disease.

Authors:  H Fillit; W H Ding; L Buee; J Kalman; L Altstiel; B Lawlor; G Wolf-Klein
Journal:  Neurosci Lett       Date:  1991-08-19       Impact factor: 3.046

9.  Association of amyloid P component with complement proteins in neurologically diseased brain tissue.

Authors:  H Akiyama; T Yamada; T Kawamata; P L McGeer
Journal:  Brain Res       Date:  1991-05-10       Impact factor: 3.252

10.  Association of lactoferrin with specific granules in rabbit heterophil leukocytes.

Authors:  M Baggiolini; C De Duve; P L Masson; J F Heremans
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

View more
  37 in total

1.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

Authors:  M A Smith; P L Harris; L M Sayre; G Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 2.  Lactoferrin and prematurity: a promising milk protein?

Authors:  Theresa J Ochoa; Stéphane V Sizonenko
Journal:  Biochem Cell Biol       Date:  2016-10-26       Impact factor: 3.626

3.  A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein.

Authors:  T Kawamata; T Taniguchi; H Mukai; M Kitagawa; T Hashimoto; K Maeda; Y Ono; C Tanaka
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

4.  Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model.

Authors:  Chuang Guo; Zhao-Hui Yang; Shuai Zhang; Rui Chai; Han Xue; Yan-Hui Zhang; Jia-Yi Li; Zhan-You Wang
Journal:  Neuropsychopharmacology       Date:  2017-01-12       Impact factor: 7.853

Review 5.  Immunomodulatory effects of lactoferrin.

Authors:  Tania Siqueiros-Cendón; Sigifredo Arévalo-Gallegos; Blanca Flor Iglesias-Figueroa; Isui Abril García-Montoya; José Salazar-Martínez; Quintín Rascón-Cruz
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

Review 6.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

7.  Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons.

Authors:  O Yasuhara; A Matsuo; I Tooyama; H Kimura; E G McGeer; P L McGeer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

9.  Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology.

Authors:  Joy G Mohanty; Hem D Shukla; Jefferey D Williamson; Lenore J Launer; Satya Saxena; Joseph M Rifkind
Journal:  Proteome Sci       Date:  2010-03-03       Impact factor: 2.480

10.  Expression of septin 3 isoforms in human brain.

Authors:  Masanori Takehashi; Seigo Tanaka; Todd Stedeford; Marek Banasik; Hiroe Tsukagoshi-Nagai; Noriaki Kinoshita; Toshio Kawamata; Kunihiro Ueda
Journal:  Gene Expr       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.